Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4476)
All Articles published online
|
Jul 28, 2011 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang ZZ, Liu X, Wang DQ, Teng MK, Niu LW, Huang AL, Liang Z. Hepatitis B virus and hepatocellular carcinoma at the miRNA level. World J Gastroenterol 2011; 17(28): 3353-3358 [PMID: 21876625 DOI: 10.3748/wjg.v17.i28.3353] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i28/3353.htm |
| Number | Citing Articles |
| 1 |
Zhaohua Hou, Jian Zhang, Qiuju Han, Chenhe Su, Jing Qu, Dongqing Xu, Cai Zhang, Zhigang Tian. Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146a. Scientific Reports 2016; 6(1) doi: 10.1038/srep26150
|
| 2 |
Seyed Shahabeddin Mortazavi-Jahromi, Mona Aslani, Abbas Mirshafiey. A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases. Immunology Letters 2020; 227: 8 doi: 10.1016/j.imlet.2020.07.008
|
| 3 |
Chengcheng Zou, Juan Chen, Ke Chen, Sen Wang, Yiyi Cao, Jinnan Zhang, Yanrui Sheng, Ailong Huang, Hua Tang. Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis. Experimental Cell Research 2015; 331(2): 352 doi: 10.1016/j.yexcr.2014.11.007
|
| 4 |
Taiyang Shi, Qinfang Hua, Zhipeng Ma, Qijun Lv. Downregulation of miR-200a-3p induced by hepatitis B Virus X (HBx) Protein promotes cell proliferation and invasion in HBV-infection-associated hepatocarcinoma. Pathology - Research and Practice 2017; 213(12): 1464 doi: 10.1016/j.prp.2017.10.020
|
| 5 |
Shanshan Chen, Hao Chen, Shanshan Gao, Shili Qiu, Hu Zhou, Mingxia Yu, Jiancheng Tu. Differential expression of plasma microRNA‐125b in hepatitis B virus‐related liver diseases and diagnostic potential for hepatitis B virus‐induced hepatocellular carcinoma. Hepatology Research 2017; 47(4): 312 doi: 10.1111/hepr.12739
|
| 6 |
Sirio Fiorino, Maria Letizia Bacchi-Reggiani, Michela Visani, Giorgia Acquaviva, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Luca Di Tommaso, Arrigo Bondi, Sergio Sabbatani, Andrea Domanico, Carlo Fabbri, Paolo Leandri, Annalisa Pession, Elio Jovine, Dario de Biase. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. World Journal of Gastroenterology 2016; 22(15): 3907-3936 doi: 10.3748/wjg.v22.i15.3907
|
| 7 |
Francesca Guerrieri, Laura Belloni, Daniel D’Andrea, Natalia Pediconi, Loredana Le Pera, Barbara Testoni, Cecilia Scisciani, Oceane Floriot, Fabien Zoulim, Anna Tramontano, Massimo Levrero. Genome-wide identification of direct HBx genomic targets. BMC Genomics 2017; 18(1) doi: 10.1186/s12864-017-3561-5
|
| 8 |
MIGUEL A. FONSECA-SANCHÉZ, CARLOS PÉREZ-PLASENCIA, JORGE FERNÁNDEZ-RETANA, ELENA ARECHAGA-OCAMPO, LAURENCE A. MARCHAT, SERGIO RODRÍGUEZ-CUEVAS, VERONICA BAUTISTA-PIÑA, ZAIRA E. ARELLANO-ANAYA, ALI FLORES-PÉREZ, JOSÉ DIAZ-CHÁVEZ, CÉSAR LÓPEZ-CAMARILLO. microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration. Oncology Reports 2013; 30(5): 2399 doi: 10.3892/or.2013.2691
|
| 9 |
Ming Wang, Dong Xi, Qin Ning. Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatology International 2017; 11(2): 171 doi: 10.1007/s12072-016-9779-5
|
| 10 |
Hong-Jie Wu, Ya Zhuo, Yan-Cai Zhou, Xin-Wei Wang, Yan-Ping Wang, Chang-Yun Si, Xin-Hong Wang. miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma. World Journal of Gastroenterology 2017; 23(25): 4569-4578 doi: 10.3748/wjg.v23.i25.4569
|
| 11 |
Fedra Mokhtari, Hami Kaboosi, Seyed Reza Mohebbi, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali Zali. Evaluation of Circulating MicroRNA-222 in Patients with Chronic Hepatitis B virus Infection as a Potential Noninvasive Diagnostic Biomarker. Iranian Journal of Medical Microbiology 2022; 16(6): 543 doi: 10.30699/ijmm.16.6.543
|
| 12 |
Kai Mao, Jianlong Zhang, Chuanchao He, Kang Xu, Jieqiong Liu, Jian Sun, Gang Wu, Cui Tan, Yunjie Zeng, Jie Wang, Zhiyu Xiao. Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib. Cancer Letters 2014; 352(2): 245 doi: 10.1016/j.canlet.2014.07.004
|
| 13 |
Lukas Weseslindtner, Iris Macheleidt, Hannah Eischeid, Robert Strassl, Harald Hofer, Theresia Popow‐Kraupp, Hans‐Peter Dienes, Heidemarie Holzmann, Margarete Odenthal. Micro RNAs mir‐106a, mir‐122 and mir‐197 are increased in severe acute viral hepatitis with coagulopathy. Liver International 2016; 36(3): 353 doi: 10.1111/liv.12961
|
| 14 |
Yiyi Cao, Juan Chen, Dan Wang, Hong Peng, Xixi Tan, Dongmei Xiong, Ailong Huang, Hua Tang. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Oncotarget 2015; 6(35): 38093 doi: 10.18632/oncotarget.5642
|
| 15 |
Gábor Lendvai, András Kiss, Ilona Kovalszky, Zsuzsa Schaff. MicroRNAs in hepatocarcinogenesis. Orvosi Hetilap 2012; 153(25): 978 doi: 10.1556/OH.2012.29387
|
| 16 |
Gang Li, Guohong Cai, Demin Li, Wen Yin. MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma. Postgraduate Medical Journal 2014; 90(1060): 106 doi: 10.1136/postgradmedj-2013-131883
|
| 17 |
Guohong Cai, Ya Liu, Wen Yin. Deregulation of microRNAs expression occurs in stages of multistep hepatocarcinogenesis: Why is it different?. Journal of Hepatology 2012; 56(6): 1425 doi: 10.1016/j.jhep.2011.12.002
|
| 18 |
Arash Letafati, Sajad Najafi, Mehran Mottahedi, Mohammad Karimzadeh, Ali Shahini, Setareh Garousi, Mohammad Abbasi-Kolli, Javid Sadri Nahand, Seyed Saeed Tamehri Zadeh, Michael R. Hamblin, Neda Rahimian, Mohammad Taghizadieh, Hamed Mirzaei. MicroRNA let-7 and viral infections: focus on mechanisms of action. Cellular & Molecular Biology Letters 2022; 27(1) doi: 10.1186/s11658-022-00317-9
|
| 19 |
Yanrui Sheng, Shijia Ding, Ke Chen, Juan Chen, Sen Wang, Chengcheng Zou, Jingnan Zhang, Yiyi Cao, Ailong Huang, Hua Tang. Functional analysis of miR-101-3p and Rap1b involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis. Biochemistry and Cell Biology 2014; 92(2): 152 doi: 10.1139/bcb-2013-0128
|
| 20 |
Yanrui Sheng, Jianbo Li, Chengcheng Zou, Sen Wang, Yiyi Cao, Jingnan Zhang, Ailong Huang, Hua Tang. Downregulation of miR-101-3p by hepatitis B virus promotes proliferation and migration of hepatocellular carcinoma cells by targeting Rab5a. Archives of Virology 2014; 159(9): 2397 doi: 10.1007/s00705-014-2084-5
|
| 21 |
Jason Lamontagne, Laura F Steel, Michael J Bouchard. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. World Journal of Gastroenterology 2015; 21(24): 7375-7399 doi: 10.3748/wjg.v21.i24.7375
|
| 22 |
Mengmeng Deng, Junwei Hou, Jun Hu, Shuo Wang, Mi Chen, Lizhao Chen, Ying Ju, Changfei Li, Songdong Meng. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma. Cancer Letters 2016; 383(1): 62 doi: 10.1016/j.canlet.2016.09.028
|
| 23 |
Xiaojie Xu, Zhongyi Fan, Lei Kang, Juqiang Han, Chengying Jiang, Xiaofei Zheng, Ziman Zhu, Huabo Jiao, Jing Lin, Kai Jiang, Lihua Ding, Hao Zhang, Long Cheng, Hanjiang Fu, Yi Song, Ying Jiang, Jiahong Liu, Rongfu Wang, Nan Du, Qinong Ye. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. Journal of Clinical Investigation 2013; doi: 10.1172/JCI64265
|
| 24 |
Mirko Tarocchi, Simone Polvani, Giada Marroncini, Andrea Galli. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World Journal of Gastroenterology 2014; 20(33): 11630-11640 doi: 10.3748/wjg.v20.i33.11630
|
| 25 |
Qingjia Chi, Xinge Geng, Kang Xu, Chunli Wang, Han Zhao. Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis. Bioscience Reports 2020; 40(6) doi: 10.1042/BSR20200124
|
| 26 |
Xiaomin Liu, Yingjian Zhang, Ping Wang, Hongyun Wang, Huanhuan Su, Xin Zhou, Lamei Zhang. HBX Protein-Induced Downregulation of microRNA-18a is Responsible for Upregulation of Connective Tissue Growth Factor in HBV Infection-Associated Hepatocarcinoma. Medical Science Monitor 2016; 22: 2492 doi: 10.12659/MSM.895943
|
| 27 |
Chengcheng Zou, Yongguo Li, Yiyi Cao, Jinnan Zhang, Jingrong Jiang, Yanrui Sheng, Sen Wang, Ailong Huang, Hua Tang. Up-regulated MicroRNA-181a induces carcinogenesis in Hepatitis B virus-related hepatocellular carcinoma by targeting E2F5. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-97
|
| 28 |
Maria Bousali, George Papatheodoridis, Dimitrios Paraskevis, Timokratis Karamitros. Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma. Microorganisms 2021; 9(8): 1787 doi: 10.3390/microorganisms9081787
|
| 29 |
Yangtao Xu, Xiaoqin He, Junjian Deng, Lin Xiong, Biao Chen, Jiayu Chen, Xiaoyu Zhang, Wenliang Chen, Xin Liu, Xinyao Hu, Jiayi Li, Shan Jiang, Yang Shen, Ximing Xu, Cinzia Signorini. ROS-Related miRNAs Regulate Immune Response and Chemoradiotherapy Sensitivity in Hepatocellular Carcinoma by Comprehensive Analysis and Experiment. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/4713518
|
| 30 |
Nearmeen M. Rashad, Amal S. El-Shal, Sally M. Shalaby, Salem Y. Mohamed. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma. Molecular and Cellular Biochemistry 2018; 447(1-2): 125 doi: 10.1007/s11010-018-3298-8
|
| 31 |
Gianna Fiorucci, Maria Vincenza Chiantore, Giorgio Mangino, Giovanna Romeo. MicroRNAs in virus-induced tumorigenesis and IFN system. Cytokine & Growth Factor Reviews 2015; 26(2): 183 doi: 10.1016/j.cytogfr.2014.11.002
|
| 32 |
Z. Herceg, M.-P. Lambert, K. van Veldhoven, C. Demetriou, P. Vineis, M. T. Smith, K. Straif, C. P. Wild. Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. Carcinogenesis 2013; 34(9): 1955 doi: 10.1093/carcin/bgt212
|
| 33 |
S. Fiorino, L. Bacchi-Reggiani, S. Sabbatani, F. Grizzi, L. di Tommaso, M. Masetti, A. Fornelli, A. Bondi, D. de Biase, M. Visani, A. Cuppini, E. Jovine, A. Pession. Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review. British Journal of Nutrition 2014; 112(11): 1751 doi: 10.1017/S0007114514002839
|
| 34 |
Hideki Wakasugi, Hideaki Takahashi, Takeshi Niinuma, Hiroshi Kitajima, Ritsuko Oikawa, Naoki Matsumoto, Yuko Takeba, Takehito Otsubo, Masayuki Takagi, Yasushi Ariizumi, Michihiro Suzuki, Chiaki Okuse, Shogo Iwabuchi, Masayuki Nakano, Noriyuki Akutsu, Jong-Hon Kang, Takeshi Matsui, Norie Yamada, Hajime Sasaki, Eiichiro Yamamoto, Masahiro Kai, Yasushi Sasaki, Shigeru Sasaki, Yasuhito Tanaka, Hiroshi Yotsuyanagi, Takeya Tsutsumi, Hiroyuki Yamamoto, Takashi Tokino, Hiroshi Nakase, Hiromu Suzuki, Fumio Itoh. Dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment. Cancer Letters 2018; 434: 91 doi: 10.1016/j.canlet.2018.07.019
|
| 35 |
Xiaopeng Dai, Wei Zhang, Hongfei Zhang, Shihui Sun, Hong Yu, Yan Guo, Zhihua Kou, Guangyu Zhao, Lanying Du, Shibo Jiang, Jianying Zhang, Junfeng Li, Yusen Zhou. Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1α. Nucleic Acids Research 2014; 42(10): 6578 doi: 10.1093/nar/gku260
|
| 36 |
Hong-Xia Fan, Hua Tang. Complex interactions between microRNAs and hepatitis B/C viruses. World Journal of Gastroenterology 2014; 20(37): 13477-13492 doi: 10.3748/wjg.v20.i37.13477
|
| 37 |
Er-Lei Zhang, Jin Gu, Zun-Yi Zhang, Ke-Shuai Dong, Bin-Yong Liang, Zhi-Yong Huang. MicroRNA expression profiling in patients with hepatocellular carcinoma of familial aggregation and hepatitis B virus infection. Oncology Letters 2017; 14(1): 971 doi: 10.3892/ol.2017.6178
|
| 38 |
Rafaella Nascimento Ferreira, Gustavo Moraes Holanda, Eliana Vieira Pinto Silva, Samir Mansour Moraes Casseb, Karla Fabiane Lopes Melo, Carlos Alberto Marques Carvalho, Juliana Abreu Lima, Pedro Fernando Costa Vasconcelos, Ana Cecília Ribeiro Cruz. Zika Virus Alters the Expression Profile of microRNA-Related Genes in Liver, Lung, and Kidney Cell Lineages. Viral Immunology 2018; 31(8): 583 doi: 10.1089/vim.2017.0186
|
| 39 |
Vivek K. Chaturvedi, Anshuman Singh, Sushil K. Dubey, Helal F. Hetta, James John, M.P. Singh. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma. Microbial Pathogenesis 2019; 128: 184 doi: 10.1016/j.micpath.2019.01.004
|
| 40 |
Hang Li, Zhen Wang, Mian Jiang, Run-ping Fang, Hui Shi, Yu Shen, Xiao-li Cai, Qian Liu, Kai Ye, Sai-jun Fan, Wei-ying Zhang, Li-hong Ye. The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways. Acta Pharmacologica Sinica 2018; 39(11): 1787 doi: 10.1038/s41401-018-0034-6
|
| 41 |
Qi Zhang, Rui Pu, Yan Du, Yifang Han, Tong Su, Hongyang Wang, Guangwen Cao. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: Potential diagnostic and prognostic markers and therapeutic targets. Cancer Letters 2012; 321(1): 1 doi: 10.1016/j.canlet.2012.03.011
|
| 42 |
Jie Hu, Zheng Wang, Bo‐Yi Liao, Lei Yu, Xue Gao, Shaohua Lu, Shuyang Wang, Zhi Dai, Xin Zhang, Qing Chen, Shuang‐Jian Qiu, Ying Wu, Hongguang Zhu, Jia Fan, Jian Zhou, Jiping Wang. Human miR‐1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients. International Journal of Cancer 2014; 135(5): 1187 doi: 10.1002/ijc.28757
|
| 43 |
Sakshi Pandita, Assim Verma, Naveen Kumar. Role of miRNAs in regulating virus replication. Animal Gene 2023; 30: 200162 doi: 10.1016/j.angen.2023.200162
|
| 44 |
Bosheng He, Ying He, Weixiang Shi, Shenchu Gong, Xiaohong Chen, Jing Xiao, Jinhua Gu, Wenbin Ding, Yilang Wang. Bioinformatics analysis of gene expression alterations in microRNA-122 knockout mice with hepatocellular carcinoma. Molecular Medicine Reports 2017; 15(6): 3681 doi: 10.3892/mmr.2017.6445
|
| 45 |
Mi Jeong Heo, Jessica Yun, Sang Geon Kim. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma. Archives of Pharmacal Research 2019; 42(1): 48 doi: 10.1007/s12272-018-01104-x
|
| 46 |
Nicholas Birkett, Mustafa Al-Zoughool, Michael Bird, Robert A. Baan, Jan Zielinski, Daniel Krewski. Overview of biological mechanisms of human carcinogens. Journal of Toxicology and Environmental Health, Part B 2019; 22(7-8): 288 doi: 10.1080/10937404.2019.1643539
|
| 47 |
Yanjing Wang, Hui Tian. miR-101 suppresses HBV replication and expression by targeting FOXO1 in hepatoma carcinoma cell lines. Biochemical and Biophysical Research Communications 2017; 487(1): 167 doi: 10.1016/j.bbrc.2017.03.171
|
| 48 |
The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019; 8(12): 1504 doi: 10.3390/cells8121504
|
| 49 |
Lucia Natarelli, Fabio Virgili, Christian Weber. SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad. International Journal of Molecular Sciences 2021; 22(22): 12243 doi: 10.3390/ijms222212243
|
| 50 |
Weiqi Xu, Jun Yu, Vincent Wai-Sun Wong. Mechanism and prediction of HCC development in HBV infection. Best Practice & Research Clinical Gastroenterology 2017; 31(3): 291 doi: 10.1016/j.bpg.2017.04.011
|
| 51 |
Jason Lamontagne, Joshua C. Mell, Michael J. Bouchard, Aleem Siddiqui. Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression. PLOS Pathogens 2016; 12(2): e1005438 doi: 10.1371/journal.ppat.1005438
|